Gainers & Losers
Fri Feb 13 2026 09:55:56- Bajaj Finance share price
- ₹1,025.752.60%
- State Bank of India share price
- ₹1,197.850.45%
Active Stocks
Fri Feb 13 2026 10:15:32- Yes Bank share price
- ₹20.86-1.18%
- Suzlon Energy share price
- ₹45.67-2.50%
- Bajaj Finance share price
- ₹1,024.102.43%
- Eternal share price
- ₹285.50-4.16%
- HDFC Bank share price
- ₹905.65-1.61%
Business News/Market/Market Stats/Alembic Pharmaceuticals share price/ Alembic Pharmaceuticals Balance Sheet Annual
Alembic Pharmaceuticals Balance Sheet Annual
765.20 -23.60 (-2.99%)Updated : 13 Feb 2026
| Fiscal Period | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Period End Date | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
| Total Liabilities Shareholders' Equity | 7,772.94 | 6,445.58 | 6,182.83 | 7,122.03 |
| Accumulated Depreciation Total | -1,593.79 | -1,328.50 | -1,069.06 | -859.49 |
| Other Liabilities Total | 124.31 | 109.50 | 106.21 | 95.81 |
| Accrued Expenses | 84.03 | 89.18 | 74.11 | 104.21 |
| Common Stock Total | 39.31 | 39.31 | 39.31 | 39.31 |
| Other Equity Total | 11.83 | 15.76 | 13.51 | 0.52 |
| Other Current Assets Total | 18.13 | 20.41 | 16.64 | 31.87 |
| Prepaid Expenses | 69.18 | 50.05 | 55.32 | 37.07 |
| Total Assets | 7,772.94 | 6,445.58 | 6,182.83 | 7,122.03 |
| Current Portof LT Debt/ Capital Leases | 15.16 | 19.83 | 16.92 | 214.97 |
| Additional Paid- In Capital | 748.39 | 748.39 | 748.39 | 748.39 |
| Cash | 83.48 | 120.21 | 75.48 | 61.09 |
| Total Equity | 5,190.94 | 4,818.20 | 4,370.47 | 5,237.55 |
| Long Term Investments | 127.21 | 93.02 | 96.33 | 118.40 |
| Retained Earnings( Accumulated Deficit) | 4,394.46 | 4,027.26 | 3,568.69 | 4,449.12 |
| Total Common Shares Outstanding | 19.66 | 19.66 | 19.66 | 19.66 |
| Property/ Plant/ Equipment Total- Gross | 4,954.56 | 4,399.56 | 4,068.77 | 4,806.74 |
| Tangible Book Valueper Share Common Eq | 264.09 | 245.12 | 222.34 | 258.58 |
| Total Liabilities | 2,582.00 | 1,627.38 | 1,812.36 | 1,884.48 |
| Total Debt | 1,257.50 | 513.16 | 722.02 | 717.11 |
| Cashand Short Term Investments | 83.48 | 120.21 | 75.48 | 61.09 |
| Total Receivables Net | 1,585.68 | 1,186.06 | 1,233.81 | 1,068.68 |
| Notes Payable/ Short Term Debt | 1,195.57 | 430.45 | 635.87 | 430.00 |
| Accounts Receivable- Trade Net | 1,399.79 | 1,024.84 | 1,046.40 | 807.13 |
| Property/ Plant/ Equipment Total- Net | 3,360.76 | 3,071.07 | 2,999.73 | 3,947.26 |
| Minority Interest | -1.42 | - | - | - |
| Total Current Liabilities | 2,412.34 | 1,455.00 | 1,636.92 | 1,716.53 |
| Total Inventory | 2,331.32 | 1,701.83 | 1,528.77 | 1,662.08 |
| Accounts Payable | 879.89 | 735.64 | 679.81 | 706.39 |
| Other Currentliabilities Total | 237.69 | 179.90 | 230.21 | 260.96 |
| Total Long Term Debt | 46.77 | 62.88 | 69.23 | 72.14 |
| Intangibles Net | 0.00 | 0.00 | 0.00 | 154.82 |
| Other Long Term Assets Total | 166.03 | 169.63 | 123.01 | 5.88 |
| Note Receivable- Long Term | 31.15 | 33.30 | 53.74 | 34.88 |
| Unrealized Gain( Loss) | -3.05 | -12.52 | 0.57 | 0.21 |
| period Length | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Current Assets | 4,087.79 | 3,078.56 | 2,910.02 | 2,860.79 |
| Capital Lease Obligations | 46.77 | 62.88 | 69.23 | 72.14 |
| Long Term Debt | - | - | - | 0.00 |
| Short Term Investments | - | - | - | 0.00 |
| Deferred Income Tax | - | - | - | 0.00 |
*All figures in crores except per share values
Alembic Pharmaceuticals Quick Links
Alembic Pharmaceuticals Dividend Alembic Pharmaceuticals Bonus Alembic Pharmaceuticals News Alembic Pharmaceuticals AGM Alembic Pharmaceuticals Rights Alembic Pharmaceuticals Splits Alembic Pharmaceuticals Board Meetings Alembic Pharmaceuticals Key Metrics Alembic Pharmaceuticals Shareholdings Alembic Pharmaceuticals Profit Loss Alembic Pharmaceuticals Cashflow Alembic Pharmaceuticals Q1 Results Alembic Pharmaceuticals Q2 Results Alembic Pharmaceuticals Q3 Results Alembic Pharmaceuticals Q4 Results
Equity Quick Links
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
1,021.60+21.80(2.18%)
1,542.15+5.80(0.38%)
1,195.70+3.20(0.27%)
2,321.20-88.85 (-3.69%)
286.90-11.00 (-3.69%)